Tag: Allylix

Evolva acquires Allylix in $59M all-share transaction: what’s the impact for industrial biotech?

Evolva acquires Allylix in $59M all-share transaction: what’s the impact for industrial biotech?

November 24, 2014 |

There’s been quite a bit of press surrounding the idea that “sugar is the new oil”, once famously described by Dr. Steven Chu as the “glucose economy”, and while the jury is still out on the economics, the technology has come along nicely. But in the meantime, it appears to be an open-and-shut case that […]

Read More

BASF invests $13.5M in Allylix; bio-based flavors and fragrances are first targets

BASF invests $13.5M in Allylix; bio-based flavors and fragrances are first targets

March 12, 2012 |

In California, BASF Venture Capital GmbH has invested $13.5 million in Allylix Inc., a U.S.-based renewable chemicals company. The BASF subsidiary led a $18.2 million financing round, joined by existing investors Tate & Lyle Ventures, Avrio Ventures and Cultivian Ventures. Allylix is developing Epivone (epi-beta-vetivone), a terpene that will initially be commercialized for use in […]

Read More